SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

NASH Race Has Room For Multiple Winners

BIOTECH: Five S.D. Cos. Trying for Liver TherapeuticIt’s a market forecast to reach upward of $35 billion. And it’s untapped — for now.

Tourism & Hospitality: Cannabiniers Wants Piece Of The Pie

According to The State of Legal Marijuana Markets report, released mid-2018 by Arcview Market Research and BDS Analytics, the legal cannabis business in the United States is projected to be a $23 billion industry by 2022. And, Little Italy-headquartered Cannabiniers, a cannabis brand management company, wants a piece of the pie.

Tease photo

Scripps, UC San Diego Health Land Opioid Treatment Grants

Scripps Mercy Hospital San Diego landed a $260,000 grant for opioid disorder treatment, the California Bridge Program recently announced.

Cellular Aquaculture Co. Seeks to ‘Grow’ Seafood

ENVIRONMENT: BlueNalu Puts A Biotech Twist on Catching Dinner

To satisfy the world’s growing appetite for seafood, one San Diego company is exploring laboratories rather than the ocean.

Tease photo

Amplyx Pharmaceuticals Snags FDA Orphan Drug Designation

San Diego-based Amplyx Pharmaceuticals’ lead drug candidate received an orphan drug designation for a condition that can be life-threatening for HIV/AIDs patients and others.

Special Report: An In-Demand Address

REAL ESTATE: Raw Land Scarce, Reuse Eyed in North County

Despite the shrinking inventory of raw land, demand for North County property is going strong, with low vacancy rates for industrial and office property.

Tease photo

AMN Healthcare Reports Fourth Quarter Results

AMN Healthcare recently reported $529 million in fourth quarter revenue, a 4 percent year-over-year increase. San Diego-based AMN is the country’s largest health care staffing agency.

Boutique CROs Find Themselves in Demand

BIOTECH: M&A in the Air at Contract Research Organizations

A crop of San Diego companies quietly play niche roles in drug development. But suitors have taken notice.

Tease photo

LIfe Sciences: Analysts Skeptical of Smith & Nephew Acquiring NuVasive

A recent report stated that Smith & Nephew Plc has held talks to buy San Diego spine surgery company NuVasive. But analysts largely said the deal doesn’t make sense for the British firm.

Tease photo

Life Sciences: Oncology Conference Puts Ideas Into Action

The 350 attendees are proven men and women of action.

Gossamer Bio Goes Public with Upsized $276M Offering

Gossamer Bio — a closely watched San Diego biotech during the government shutdown — made its public debut Feb. 8 with an upsized $276 million offering.

Tease photo

Special Report: Life Science Firms Show Increased Interest In North County

BIOTECH: Why Pay More Is One Company’s Philosophy

When Ionis Pharmaceuticals was looking for a new home, it chose Carlsbad over the more traditional sites for life science companies in central San Diego County.

Tease photo

Agriculture Biotech Cibus Postpones IPO

San Diego-based Cibus postponed its initial public offering, citing “current market and technical conditions.”

Arcturus Therapeutics Regains Full Rights to Drug Candidate

San Diego-based Arcturus Therapeutics on Feb. 12 reassumed full rights to its flagship drug candidate, after CureVac opted out of development plans.

Scripps to Build Larger Behavioral Health Unit

Through a joint venture Scripps Health has planned a 120-bed behavioral health facility in Chula Vista that will replace a smaller behavioral health unit at Scripps Mercy Hospital.

Qualcomm Sells Mobile Health Subsidiary

Qualcomm Life was sold to private equity firm Francisco Partners. It will be renamed Capsule Technologies.

Tease photo

Prev